Cargando…

Impact of somatic mutations on prognosis in resected non‐small‐cell lung cancer: The Japan Molecular Epidemiology for lung cancer study

BACKGROUND: To report the follow up data and clinical outcomes of the JME study (UMIN 000008177), a prospective, multicenter, molecular epidemiology examination of 876 surgically resected non‐small‐cell lung cancer (NSCLC) cases, and the impact of somatic mutations (72 cancer‐associated genes) on re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tamiya, Akihiro, Koh, Yasuhiro, Isa, Shun‐ichi, Kubo, Akihito, Ando, Masahiko, Saka, Hideo, Yoshimoto, Naoki, Takeo, Sadanori, Adachi, Hirofumi, Tagawa, Tsutomu, Kawashima, Osamu, Yamashita, Motohiro, Kataoka, Kazuhiko, Takenoyama, Mitsuhiro, Takeuchi, Yukiyasu, Watanabe, Katsuya, Matsumura, Akihide, Kawaguchi, Tomoya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7131842/ https://www.ncbi.nlm.nih.gov/pubmed/32022477 http://dx.doi.org/10.1002/cam4.2897

Ejemplares similares

Multiplex Ultrasensitive Genotyping of Patients with Non-Small Cell Lung Cancer for Epidermal Growth Factor Receptor (EGFR) Mutations by Means of Picodroplet Digital PCR
por: Watanabe, Masaru, et al.
Publicado: (2017)

Can smoking duration alone replace pack-years to predict the risk of smoking-related oncogenic mutations in non-small cell lung cancer? A cross-sectional study in Japan
por: Ogawa, Koichi, et al.
Publicado: (2020)

Prognostic impact of pretreatment T790M mutation on outcomes for patients with resected, EGFR-mutated, non-small cell lung cancer
por: Matsumoto, Yoshiya, et al.
Publicado: (2022)

Does short-term cessation of smoking before lung resections reduce the risk of complications?
por: Takenaka, Tomoyoshi, et al.
Publicado: (2020)

Differential properties of KRAS transversion and transition mutations in non-small cell lung cancer: associations with environmental factors and clinical outcomes
por: Sato, Koichi, et al.
Publicado: (2022)

A randomized phase II study to assess the effect of adjuvant immunotherapy using α-GalCer-pulsed dendritic cells in the patients with completely resected stage II–IIIA non-small cell lung cancer: study protocol for a randomized controlled trial
por: Saka, Hideo, et al.
Publicado: (2017)

Molecular analysis of human papillomavirus in never-smokers with non-small cell lung cancer
por: ISA, SHUN-ICHI, et al.
Publicado: (2015)

Polymorphisms in intron 1 of the EGFR gene in non-small cell lung cancer patients
por: SHITARA, MASAYUKI, et al.
Publicado: (2012)

Insights into brain metastasis in patients with ALK+ lung cancer: is the brain truly a sanctuary?
por: Toyokawa, Gouji, et al.
Publicado: (2015)

Paired analysis of tumor mutation burden for lung adenocarcinoma and associated idiopathic pulmonary fibrosis
por: Yoneshima, Yasuto, et al.
Publicado: (2021)

Chronological analysis of the gut microbiome for efficacy of atezolizumab‐based immunotherapy in non‐small cell lung cancer: Protocol for a multicenter prospective observational study
por: Shoji, Fumihiro, et al.
Publicado: (2022)

Pretreatment advanced lung cancer inflammation index (ALI) for predicting early progression in nivolumab‐treated patients with advanced non–small cell lung cancer
por: Shiroyama, Takayuki, et al.
Publicado: (2017)

Differences in molecular epidemiology of lung cancer among ethnicities (Asian vs. Caucasian)
por: Izumi, Motohiro, et al.
Publicado: (2020)

Will the Requirement by the US FDA to Simultaneously Co-Develop Companion Diagnostics (CDx) Delay the Approval of Receptor Tyrosine Kinase Inhibitors for RTK-Rearranged (ROS1-, RET-, AXL-, PDGFR-α-, NTRK1-) Non-Small Cell Lung Cancer Globally?
por: Ou, Sai-Hong Ignatius, et al.
Publicado: (2014)

Delayed pseudoprogression of lung adenocarcinoma accompanied with interstitial lung disease during chemotherapy after nivolumab treatment
por: Kumagai, Toru, et al.
Publicado: (2017)

Rapidly Destructive Coxarthrosis as a Potential Side Effect of Crizotinib in a Patient with ROS1-Positive Lung Adenocarcinoma
por: Takamori, Shinkichi, et al.
Publicado: (2020)

Autologous Tumor‐specific Cytotoxic T Lymphocytes in a Patient with Lung Adenocarcinoma: Implications of the Shared Antigens Expressed in HLA‐A24 Lung Cancer Cells
por: Takenoyama, Mitsuhiro, et al.
Publicado: (1998)

Prognostic value of postoperative decrease in serum albumin on surgically resected early-stage non-small cell lung carcinoma: A multicenter retrospective study
por: Kinoshita, Fumihiko, et al.
Publicado: (2021)

Population pharmacokinetics of afatinib and exposure-safety relationships in Japanese patients with EGFR mutation-positive non-small cell lung cancer
por: Nakao, Keiko, et al.
Publicado: (2019)

Complete Blood Cell Count-Derived Inflammatory Biomarkers in Early-Stage Non-Small-Cell Lung Cancer
por: Shoji, Fumihiro, et al.
Publicado: (2020)

Cumulative experience of the anterior approach in robot-assisted thoracic surgery for lung cancer patients
por: Yamazaki, Koji, et al.
Publicado: (2021)

Stage IV pleomorphic carcinoma of the lung without recurrence for 6 years: a case report
por: Miura, Naoko, et al.
Publicado: (2017)

Clinical significance of preoperative inflammatory markers in non-small cell lung cancer patients: A multicenter retrospective study
por: Takada, Kazuki, et al.
Publicado: (2020)

Association of thyroid transcription factor‐1 with the efficacy of immune‐checkpoint inhibitors in patients with advanced lung adenocarcinoma
por: Nakahama, Kenji, et al.
Publicado: (2022)

Dramatic response to pembrolizumab with chemotherapy followed by salvage surgery in a lung cancer patient
por: Saito, Shunichi, et al.
Publicado: (2021)

Brain cavernous hemangioma mimicking radiation‐induced necrosis in a patient with non‐small cell lung cancer
por: Takamori, Shinkichi, et al.
Publicado: (2020)

The impact of immune-inflammation-nutritional parameters on the prognosis of non-small cell lung cancer patients treated with atezolizumab
por: Matsubara, Taichi, et al.
Publicado: (2020)

Cohesion between pulmonary artery and bronchus after immune checkpoint inhibitor therapy in a lung cancer patient
por: Takamori, Shinkichi, et al.
Publicado: (2020)

Peripheral TIGIT+ T Follicular Helper Cells That Produce High Levels of Interleukin-21 via OX40 Represent Disease Activity in IgG4-Related Disease
por: Akiyama, Mitsuhiro, et al.
Publicado: (2021)

Preoperative Immune-Nutritional Abnormality Predicts Poor Outcome in Elderly Non-Small-Cell Lung Cancer Patients with Comorbidities
por: Miura, Naoko, et al.
Publicado: (2020)

Subpleural fibrotic interstitial lung abnormalities are implicated in non-small cell lung cancer radiotherapy outcomes
por: Ito, Makoto, et al.
Publicado: (2023)

The Induction of Cytotoxic T Lymphocytes against HLA‐A Locus‐matched Lung Adenocarcinoma in Patients with Non‐small Cell Lung Cancer
por: Yoshino, Ichiro, et al.
Publicado: (1997)

Vascular endothelial growth factor receptor 2 expression and immunotherapy efficacy in non–small cell lung cancer
por: Nakahama, Kenji, et al.
Publicado: (2022)

Metastatic site as a predictor of nivolumab efficacy in patients with advanced non-small cell lung cancer: A retrospective multicenter trial
por: Tamiya, Motohiro, et al.
Publicado: (2018)

Histological conversion from adenocarcinoma to small cell carcinoma of the lung after treatment with an immune checkpoint inhibitor: a case report
por: Miura, Naoko, et al.
Publicado: (2020)

Uncommon features of surgically resected ALK-positive cavitary lung adenocarcinoma: a case report
por: Takamori, Shinkichi, et al.
Publicado: (2017)

Development of adoptive immunotherapy with KK‐LC‐1‐specific TCR‐transduced γδT cells against lung cancer cells
por: Ichiki, Yoshinobu, et al.
Publicado: (2020)

Preoperative inhalation therapy for patients with chronic obstructive pulmonary disease undergoing lung surgery: a retrospective study
por: Machino, Ryusuke, et al.
Publicado: (2022)

Clinical benefit of platinum doublet combination therapy in older adults with advanced non‐small cell lung cancer: A prospective multicenter study by the National Hospital Organization in Japan
por: Shimokawa, Mototsugu, et al.
Publicado: (2023)

Interstitial Lung Disease Induced by Osimertinib for Epidermal Growth Factor Receptor (EGFR) T790M-positive Non-small Cell Lung Cancer
por: Matsumoto, Yoshiya, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_mto689ioetmjnld59mddmc9mpt